U.S. markets close in 5 hours 8 minutes
  • S&P 500

    3,888.20
    +43.12 (+1.12%)
     
  • Dow 30

    31,293.72
    +256.04 (+0.82%)
     
  • Nasdaq

    11,548.89
    +187.04 (+1.65%)
     
  • Russell 2000

    1,760.91
    +33.36 (+1.93%)
     
  • Crude Oil

    103.96
    +5.43 (+5.51%)
     
  • Gold

    1,744.80
    +8.30 (+0.48%)
     
  • Silver

    19.31
    +0.15 (+0.76%)
     
  • EUR/USD

    1.0183
    -0.0001 (-0.01%)
     
  • 10-Yr Bond

    2.9690
    +0.0560 (+1.92%)
     
  • GBP/USD

    1.1998
    +0.0076 (+0.64%)
     
  • USD/JPY

    135.8700
    -0.0450 (-0.03%)
     
  • BTC-USD

    20,848.09
    +645.25 (+3.19%)
     
  • CMC Crypto 200

    455.15
    +10.83 (+2.44%)
     
  • FTSE 100

    7,201.36
    +93.59 (+1.32%)
     
  • Nikkei 225

    26,490.53
    +382.88 (+1.47%)
     

Charges pressed by prosecutor against a member of Orion’s Board of Directors for a suspected securities market offence dismissed

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Orion Oyj
Orion Oyj

ORION CORPORATION  STOCK EXCHANGE RELEASE 10 JUNE 2022 7:15 p.m. EEST          
        
Charges pressed by prosecutor against a member of Orion’s Board of Directors for a suspected securities market offence dismissed

Charges pressed by prosecutor against a member of Orion’s Board of Directors for a suspected securities market offence dismissed


It has come to the attention of Orion Corporation the charges pressed by prosecutor against Ari Lehtoranta, a member of Orion’s Board of Directors, in a securities markets case concerning suspected disclosure offence have been dismissed.


According to Orion’s knowledge, the matter was related to Mr. Lehtoranta’s operations as the CEO of Nokian Tyres plc in 2015-2016. Orion Corporation disclosed the prosecutor’s decision to press charges in its stock exchange release of 29 October 2020. The suspected offence was not related to Orion. Orion will not comment the matter.

Orion Corporation

Timo Lappalainen

President and CEO

   

Olli Huotari

SVP, Corporate Functions

 

Contact person:
Terhi Ormio, VP, Communications
tel. +358 10 426 4646

Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
http://www.orion.fi/en
http://www.twitter.com/OrionCorpIR

Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are oncology and pain. Orion's net sales in 2021 amounted to EUR 1,041 million and the company had about 3,350 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki.